Cites,Authors,Title,Year,Source,Publisher,ArticleURL,CitesURL,GSRank,QueryDate,Type,DOI,ISSN,CitationURL,Volume,Issue,StartPage,EndPage,ECC,CitesPerYear,CitesPerAuthor,AuthorCount,Age
808,"TI Oprea, AM Davis, SJ Teague, PD Leeson","Is There a Difference Between Leads and Drugs? A Historical Perspective.",2001,"Journal of chemical information and computer sciences","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13803941208208769371",1,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:IWHjjKOFINEC",41,5,1308,1315,808,44.89,202,4,18
694,"SJ Teague, AM Davis, PD Leeson, T Oprea","The design of leadlike combinatorial libraries",1999,"Angewandte Chemie International Edition","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10033862615584187323,10481655029282925675,1426293939881523714",2,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:k_IJM867U9cC",38,24,3743,3748,694,34.70,174,4,20
670,"CG Bologa, CM Revankar, SM Young, BS Edwards, JB Arterburn, ...","Virtual and biomolecular screening converge on a selective agonist for GPR30",2006,"Nature chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5857318446494061381",3,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:O3NaXMp0MMsC",2,4,207,207,670,51.54,112,6,13
566,"ER Prossnitz, JB Arterburn, HO Smith, TI Oprea, LA Sklar, HJ Hathaway","Estrogen signaling through the transmembrane G protein–coupled receptor GPR30",2008,"Annu. Rev. Physiol.","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5849549489229364399",4,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:RGFaLdJalmkC",70,,165,190,566,51.45,94,6,11
532,"TI Oprea","Property distribution of drug-related chemical databases",2000,"Journal of computer-aided molecular design","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7828039317908674688",5,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:GnPB-g6toBAC",14,3,251,264,532,28.00,532,1,19
486,"MM Hann, TI Oprea","Pursuing the leadlikeness concept in pharmaceutical research",2004,"Current opinion in chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4395259915386176316",6,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:ns9cj8rnVeAC",8,3,255,263,486,32.40,243,2,15
431,"R Santos, O Ursu, A Gaulton, AP Bento, RS Donadi, CG Bologa, ...","A comprehensive map of molecular drug targets",2017,"Nature reviews Drug discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2373672910109154446",7,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:7wO8s98CvbsC",16,1,19,19,431,215.50,62,7,2
407,"MK Dennis, R Burai, C Ramesh, WK Petrie, SN Alcon, TK Nayak, ...","In vivo effects of a GPR30 antagonist",2009,"Nature chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9112773686963379561",8,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:ldfaerwXgEUC",5,6,421,421,407,40.70,58,7,10
403,"E Brailoiu, SL Dun, GC Brailoiu, K Mizuo, LA Sklar, TI Oprea, ER Prossnitz, ...","Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system",2007,"Journal of Endocrinology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=248969345634889884",9,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:lSLTfruPkqcC",193,2,311,321,403,33.58,50,8,12
403,"L Albanito, A Madeo, R Lappano, A Vivacqua, V Rago, A Carpino, ...","G protein–coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells",2007,"Cancer research","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13319686880005366565",10,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:70eg2SAEIzsC",67,4,1859,1866,403,33.58,58,7,12
357,"LZ Benet, F Broccatelli, TI Oprea","BDDCS applied to over 900 drugs",2011,"The AAPS journal","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11359298234231681533",11,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:IjCSPb-OGe4C",13,4,519,547,357,44.63,119,3,8
304,"TI Oprea, J Gottfries","Chemography: the art of navigating in chemical space",2001,"Journal of combinatorial chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6815067546664113843",12,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:NMxIlDl6LWMC",3,2,157,166,304,16.89,152,2,18
301,"RD Head, ML Smythe, TI Oprea, CL Waller, SM Green, GR Marshall","VALIDATE: A new method for the receptor-based prediction of binding affinities of novel ligands",1996,"Journal of the American Chemical society","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4233736476324891054",13,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:NaGl4SEjCO4C",118,16,3959,3969,301,13.09,50,6,23
286,"TI Oprea, H Matter","Integrating virtual screening in lead discovery",2004,"Current opinion in chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16435902712851693882",14,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:J_g5lzvAfSwC",8,4,349,358,286,19.07,143,2,15
269,"TI Oprea","Current trends in lead discovery: Are we looking at the appropriate property",2002,"Journal of computer-aided molecular design 16 (5-6)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9706949337559083636,97224203851681130",15,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:1qzjygNMrQYC",,,325,334,269,15.82,269,1,17
0,"TI Oprea","Current trends in lead discovery: Are we looking for the appropriate properties?",2002,"Journal of computer-aided molecular design 16 (5-6)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9706949337559083636",16,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:vV6vV6tmYwMC",,,325,334,0,0.00,0,1,17
230,"BS Edwards, T Oprea, ER Prossnitz, LA Sklar","Flow cytometry for high-throughput, high-content screening",2004,"Current opinion in chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4772781228680655798",17,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:2P1L_qKh6hAC",8,4,392,398,230,15.33,58,4,15
226,"CL Waller, TI Oprea, K Chae, HK Park, KS Korach, SC Laws, TE Wiese, ...","Ligand-based identification of environmental estrogens",1996,"Chemical research in toxicology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1289838860059062149",18,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:RYcK_YlVTxYC",9,8,1240,1248,226,9.83,28,8,23
216,"J Rosén, J Gottfries, S Muresan, A Backlund, TI Oprea","Novel chemical space exploration via natural products",2009,"Journal of medicinal chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4272439634349310937",19,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:3s1wT3WcHBgC",52,7,1953,1962,216,21.60,43,5,10
206,"CL Waller, TI Oprea, A Giolitti, GR Marshall","Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules",1993,"Journal of medicinal chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17644309617259640981",20,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:35N4QoGY0k4C",36,26,4152,4160,206,7.92,52,4,26
200,"EA Ariazi, E Brailoiu, S Yerrum, HA Shupp, MJ Slifker, HE Cunliffe, ...","The G protein–coupled receptor GPR30 inhibits proliferation of estrogen receptor–positive breast cancer cells",2010,"Cancer research","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4145533673231131522",21,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:f2IySw72cVMC",70,3,1184,1194,200,22.22,29,7,9
185,"MK Dennis, AS Field, R Burai, C Ramesh, WK Petrie, CG Bologa, ...","Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity",2011,"The Journal of steroid biochemistry and molecular biology 127 (3-5)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15393957668091206306",22,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:9yKSN-GCB0IC",,,358,366,185,23.13,26,7,8
185,"S Wetzel, K Klein, S Renner, D Rauh, TI Oprea, P Mutzel, H Waldmann","Interactive exploration of chemical space with Scaffold Hunter",2009,"Nature chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=846492144124716156",23,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:fPk4N6BV_jEC",5,8,581,581,185,18.50,26,7,10
169,"ER Prossnitz, TI Oprea, LA Sklar, JB Arterburn","The ins and outs of GPR30: a transmembrane estrogen receptor",2008,"The Journal of steroid biochemistry and molecular biology 109 (3-5)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14778410350840443693",24,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:SeFeTyx0c_EC",,,350,353,169,15.36,42,4,11
163,"TI Oprea, C Bologa, M Olah","Compound selection for virtual screening",2005,"Virtual Screening in Drug Discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7468164442585326109,16353872083547179400",25,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:5ugPr518TE4C",,,89,106,163,11.64,54,3,14
156,"AC Good, TI Oprea","Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection?",2008,"Journal of computer-aided molecular design 22 (3-4)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5835587492752083395",26,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:pqnbT2bcN3wC",,,169,178,156,14.18,78,2,11
155,"J Hert, MJ Keiser, JJ Irwin, TI Oprea, BK Shoichet","Quantifying the Relationships among Drug Classes.",2008,"Journal of chemical information and modeling","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=208603079479493873",27,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:qxL8FJ1GzNcC",48,4,755,765,155,14.09,31,5,11
150,"TI Oprea, GR Marshall","Receptor-Based Prediction of Affinity",1998,"3D QSAR in Drug Design: Ligand-Protein Interactions and Molecular Similarity …","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11227342124861110734,1578640187524159428",28,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:LjlpjdlvIbIC",,,,,150,7.14,75,2,21
147,"V Păunescu, E Deak, D Herman, IR Siska, G T˘ anasie, C Bunu, S Anghel, ...","In vitro differentiation of human mesenchymal stem cells to epithelial lineage",2007,"Journal of cellular and molecular medicine","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7432798052318777319",29,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:u_35RYKgDlwC",11,3,502,508,147,12.25,18,8,12
143,"TI Oprea","3D QSAR modeling in drug design",2003,"Computational Medicinal Chemistry for drug discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10296422132617315838,9008992444940334099",30,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:mvPsJ3kp5DgC",,,597,648,143,8.94,143,1,16
141,"TI Oprea, CL Waller, GR Marshall","Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of …",1994,"J. Med. Chem","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5238073651271156430,13714924932865746749",31,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:PELIpwtuRlgC",37,14,2206,2215,141,5.64,47,3,25
139,"M Olah, M Mracec, L Ostopovici, R Rad, A Bora, N Hadaruga, I Olah, ...","WOMBAT: world of molecular bioactivity",2005,"Chemoinformatics in drug discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2081125344081614662",32,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:g5m5HwL7SMYC",1,,223,239,139,9.93,17,8,14
136,"TI Oprea, G Hummer, AE García","Identification of a functional water channel in cytochrome P450 enzymes",1997,"Proceedings of the National Academy of Sciences","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16946380062422659291",33,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:ZHo1McVdvXMC",94,6,2133,2138,136,6.18,45,3,22
134,"TI Oprea, JE Bauman, CG Bologa, T Buranda, A Chigaev, BS Edwards, ...","Drug repurposing from an academic perspective",2011,"Drug Discovery Today: Therapeutic Strategies 8 (3-4)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3205115324454854435",34,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:aqlVkmm33-oC",,,61,69,134,16.75,19,7,8
133,"TI OPREA","Cheminformatics in drug discovery (Methods and Principles in Medicinal Chemistry vol. 23)",2005,"Wiley-VCH","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10180260950056014629,10971470759673471693,6231102135021311641",35,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:TQgYirikUcIC",1,,493,493,133,9.50,133,1,14
0,"TI Oprea, CL Waller, GR Marshall","Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of …",1994,"Journal of medicinal chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5238073651271156430",36,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:M05iB0D1s5AC",37,14,2206,2215,0,0.00,0,3,25
131,"AB Jensen, PL Moseley, TI Oprea, SG Ellesøe, R Eriksson, H Schmock, ...","Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients",2014,"Nature communications","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11987064734542149183",37,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:fFSKOagxvKUC",5,,4022,4022,131,26.20,19,7,5
131,"L Zhang, H Zhu, TI Oprea, A Golbraikh, A Tropsha","QSAR modeling of the blood–brain barrier permeability for diverse organic compounds",2008,"Pharmaceutical research","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8777093199402314625",38,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:dfsIfKJdRG4C",25,8,1902,1902,131,11.91,26,5,11
130,"TI Oprea, A Tropsha, JL Faulon, MD Rintoul","Systems chemical biology",2007,"Nature chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11241342636485646312,2215068290214897181",39,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:M3NEmzRMIkIC",3,8,447,447,130,10.83,33,4,12
129,"ER Prossnitz, LA Sklar, TI Oprea, JB Arterburn","GPR30: a novel therapeutic target in estrogen-related disease",2008,"Trends in pharmacological sciences","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3234438607269692749",40,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:4OULZ7Gr8RgC",29,3,116,123,129,11.73,32,4,11
123,"TI Oprea, J Mestres","Drug repurposing: far beyond new targets for old drugs",2012,"The AAPS journal","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10834143930360894633",41,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:AXPGKjj_ei8C",14,4,759,763,123,17.57,62,2,7
121,"T Oprea","Virtual screening in lead discovery: a viewpoint",2002,"Molecules","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8186648045043723631",42,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:rO6llkc54NcC",7,1,51,62,121,7.12,121,1,17
120,"TI Oprea, J Gottfries","Toward minimalistic modeling of oral drug absorption",1999,"Journal of Molecular Graphics and Modelling 17 (5-6)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8405262905812287838,16162304950245594846",43,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:HoB7MX3m0LUC",,,261,274,120,6.00,60,2,20
115,"S Renner, WAL Van Otterlo, MD Seoane, S Möcklinghoff, B Hofmann, ...","Bioactivity-guided mapping and navigation of chemical space",2009,"Nature chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1988907910315948104",44,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:bFI3QPDXJZMC",5,8,585,585,115,11.50,19,6,10
113,"M Olah, C Bologa, TI Oprea","An automated PLS search for biologically relevant QSAR descriptors",2004,"Journal of computer-aided molecular design 18 (7-9)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2571888991297988735",45,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:D03iK_w7-QYC",,,437,449,113,7.53,38,3,15
109,"JP Slack, A Brockhoff, C Batram, S Menzel, C Sonnabend, S Born, ...","Modulation of bitter taste perception by a small molecule hTAS2R antagonist",2010,"Current Biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18145734407006309353",46,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:CHSYGLWDkRkC",20,12,1104,1109,109,12.11,16,7,9
109,"TI Oprea, TK Allu, DC Fara, RF Rad, L Ostopovici, CG Bologa","Lead-like, drug-like or “Pub-like”: how different are they?",2007,"Journal of computer-aided molecular design 21 (1-3)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5854102313179143325",47,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:maZDTaKrznsC",,,113,119,109,9.08,18,6,12
108,"BS Edwards, C Bologa, SM Young, KV Balakin, ER Prossnitz, ...","Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists",2005,"Molecular pharmacology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11024176825427461943",48,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:zA6iFVUQeVQC",68,5,1301,1310,108,7.71,18,6,14
107,"F Broccatelli, E Carosati, A Neri, M Frosini, L Goracci, TI Oprea, ...","A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields",2011,"Journal of medicinal chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4190056596024290373",49,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:d1gkVwhDpl0C",54,6,1740,1751,107,13.38,15,7,8
106,"TI Oprea, CG Bologa, S Boyer, RF Curpan, RC Glen, AL Hopkins, ...","A crowdsourcing evaluation of the NIH chemical probes",2009,"Nature chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15235585545927955014,7804265278935336968",50,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:EUQCXRtRnyEC",5,7,441,441,106,10.60,15,7,10
102,"DT Manallack, RJ Prankerd, E Yuriev, TI Oprea, DK Chalmers","The significance of acid/base properties in drug discovery",2013,"Chemical Society Reviews","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6769231452320697296",51,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:W5xh706n7nkC",42,2,485,496,102,17.00,20,5,6
98,"M Olah, R Rad, L Ostopovici, A Bora, N Hadaruga, D Hadaruga, ...","WOMBAT and WOMBAT‐PK: bioactivity databases for lead and drug discovery",2007,"Chemical biology: from small molecules to systems biology and drug design 1 …","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5553502617390434075",52,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:xtRiw3GOFMkC",,,,,98,8.17,14,7,12
92,"L Hong, SR Kenney, GK Phillips, D Simpson, CE Schroeder, J Nöth, ...","Characterization of a Cdc42 protein inhibitor and its use as a molecular probe",2013,"Journal of Biological Chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15037545384117711577,13174736765152000250",53,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:i2xiXl-TujoC",288,12,8531,8543,92,15.33,13,7,6
88,"O Ursu, A Rayan, A Goldblum, TI Oprea","Understanding drug‐likeness",2011,"Wiley Interdisciplinary Reviews: Computational Molecular Science","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3047340773300263527",54,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:eQOLeE2rZwMC",1,5,760,781,88,11.00,22,4,8
88,"Q Li, FS Jørgensen, T Oprea, S Brunak, O Taboureau","hERG classification model based on a combination of support vector machine method and GRIND descriptors",2008,"Molecular pharmaceutics","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15232551602736497776",55,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:abG-DnoFyZgC",5,1,117,127,88,8.00,18,5,11
88,"TI Oprea","Chemical space navigation in lead discovery",2002,"Current opinion in chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11598748062475264085",56,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:YFjsv_pBGBYC",6,3,384,389,88,5.18,88,1,17
86,"TI Oprea, I Zamora, AL Ungell","Pharmacokinetically based mapping device for chemical space navigation",2002,"Journal of combinatorial chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10114213603707701661",57,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:BqipwSGYUEgC",4,4,258,266,86,5.06,29,3,17
84,"TI Oprea, SK Nielsen, O Ursu, JJ Yang, O Taboureau, SL Mathias, ...","Associating drugs, targets and clinical outcomes into an integrated network affords a new platform for computer‐aided drug repurposing",2011,"Molecular informatics 30 (2‐3)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7086798512830606782",58,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:uWQEDVKXjbEC",,,100,111,84,10.50,12,7,8
80,"G P Tegos, M Haynes, J Jacob Strouse, M Md T Khan, C G Bologa, ...","Microbial efflux pump inhibition: tactics and strategies",2011,"Current pharmaceutical design","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1986485595554907819",59,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:wbdj-CoPYUoC",17,13,1291,1302,80,10.00,13,6,8
79,"MM Olah, CG Bologa, TI Oprea","Strategies for compound selection",2004,"Current drug discovery technologies","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3467546177888717164",60,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:pyW8ca7W8N0C",1,3,211,220,79,5.27,26,3,15
77,"SL Schreiber, JD Kotz, M Li, J Aubé, CP Austin, JC Reed, H Rosen, ...","Advancing biological understanding and therapeutics discovery with small-molecule probes",2015,"Cell","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13592571475521353672",61,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:LgRImbQfgY4C",161,6,1252,1265,77,19.25,10,8,4
72,"SL Dun, GC Brailoiu, X Gao, E Brailoiu, JB Arterburn, ER Prossnitz, ...","Expression of estrogen receptor GPR30 in the rat spinal cord and in autonomic and sensory ganglia",2009,"Journal of neuroscience research","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13247664736590640953",62,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:1sJd4Hv_s6UC",87,7,1610,1619,72,7.20,10,7,10
72,"SM Young, C Bologa, ER Prossnitz, TI Oprea, LA Sklar, BS Edwards","High-throughput screening with HyperCyt® flow cytometry to detect small molecule formylpeptide receptor ligands",2005,"Journal of biomolecular screening","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14712150138548283949",63,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:b0M2c_1WBrUC",10,4,374,382,72,5.14,12,6,14
71,"TI Oprea, CL Waller","Theoretical and Practical Aspects of Three‐Dimensional Quantitative Structure‐Activity Relationships",1997,"Reviews in Computational Chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6054348392314793634",64,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:yD5IFk8b50cC",,,127,182,71,3.23,36,2,22
69,"I Zamora, T Oprea, G Cruciani, M Pastor, AL Ungell","Surface descriptors for protein− ligand affinity prediction",2003,"Journal of medicinal chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8394004065842577564",65,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:_xSYboBqXhAC",46,1,25,33,69,4.31,14,5,16
69,"TI Oprea, AE García","Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors",1996,"Journal of computer-aided molecular design","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7396864411605313764",66,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:cFHS6HbyZ2cC",10,3,186,200,69,3.00,35,2,23
68,"AS Kiselyov, MN Semenova, NB Chernyshova, A Leitao, AV Samet, ...","Novel derivatives of 1, 3, 4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays",2010,"European journal of medicinal chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7938549734610285761",67,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:K3LRdlH-MEoC",45,5,1683,1697,68,7.56,11,6,9
63,"O Ursu, J Holmes, J Knockel, CG Bologa, JJ Yang, SL Mathias, SJ Nelson, ...","DrugCentral: online drug compendium",2016,"Nucleic acids research, gkw","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17242575589689045832",68,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:1taIhTC69MYC",993,,,,63,21.00,8,8,3
63,"GC Brailoiu, TI Oprea, P Zhao, ME Abood, E Brailoiu","Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide",2011,"Journal of Biological Chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9716747262375728153",69,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:738O_yMBCRsC",286,33,29166,29174,63,7.88,13,5,8
63,"O Taboureau, SK Nielsen, K Audouze, N Weinhold, D Edsgärd, FS Roque, ...","ChemProt: a disease chemical biology database",2010,"Nucleic acids research 39 (suppl_1), D367-D","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11432106614268379093",70,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:JV2RwH3_ST0C",372,,,,63,7.00,9,7,9
62,"F Broccatelli, G Cruciani, LZ Benet, TI Oprea","BDDCS class prediction for new molecular entities",2012,"Molecular pharmaceutics","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7449594197634624060",71,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:ZeXyd9-uunAC",9,3,570,580,62,8.86,16,4,7
60,"TI Oprea, A Tropsha","Target, chemical and bioactivity databases–integration is key",2006,"Drug Discovery Today: Technologies","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9597906807628839973",72,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:KxtntwgDAa4C",3,4,357,365,60,4.62,30,2,13
0,"TI Oprea, GR Marshall","Receptor-based prediction of binding affinities",1998,"Perspectives in drug discovery and design","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1578640187524159428",73,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:a0OBvERweLwC",9,,35,61,0,0.00,0,2,21
56,"S Kim Kjærulff, L Wich, J Kringelum, UP Jacobsen, I Kouskoumvekaki, ...","ChemProt-2.0: visual navigation in a disease chemical biology database",2012,"Nucleic acids research 41 (D1), D464-D","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5545431839668404764",74,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:dTyEYWd-f8wC",469,,,,56,8.00,9,6,7
54,"DT Nguyen, S Mathias, C Bologa, S Brunak, N Fernandez, A Gaulton, ...","Pharos: collating protein information to shed light on the druggable genome",2016,"Nucleic acids research 45 (D1), D995-D","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11310653513476481027",75,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:WC23djZS0W4C",1002,,,,54,18.00,8,7,3
54,"TI Oprea, J Gottfries, V Sherbukhin, P Svensson, TC Kühler","Chemical information management in drug discovery: optimizing the computational and combinatorial chemistry interfaces",2000,"Journal of Molecular Graphics and Modelling 18 (4-5)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3395208182022057825",76,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:dshw04ExmUIC",,,512,524,54,2.84,11,5,19
54,"TI Opera, CL Waller, GR Marshall","3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results.",1994,"Drug design and discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2168612667733912795",77,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:J-pR_7NvFogC",12,1,29,51,54,2.16,18,3,25
53,"JO Agola, L Hong, Z Surviladze, O Ursu, A Waller, JJ Strouse, ...","A Competitive Nucleotide Binding Inhibitor: In Vitro Characterization of Rab7 GTPase Inhibition",2012,"ACS chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12034710342660375688",78,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:ZuybSZzF8UAC",7,6,1095,1108,53,7.57,8,7,7
53,"SW Burchiel, TA Thompson, FT Lauer, TI Oprea","Activation of dioxin response element (DRE)-associated genes by benzo (a) pyrene 3, 6-quinone and benzo (a) pyrene 1, 6-quinone in MCF-10A human mammary epithelial cells",2007,"Toxicology and applied pharmacology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11242787469321866654",79,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:UxriW0iASnsC",221,2,203,214,53,4.42,13,4,12
53,"T Olsson, TI Oprea","Cheminformatics: a tool for decision-makers in drug discovery.",2001,"Current opinion in drug discovery & development","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15884197704967143101",80,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:NhqRSupF_l8C",4,3,308,313,53,2.94,27,2,18
52,"F Broccatelli, CA Larregieu, G Cruciani, TI Oprea, LZ Benet","Improving the prediction of the brain disposition for orally administered drugs using BDDCS",2011,"Advanced Drug Delivery Reviews","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13373113691048332811",81,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:hqOjcs7Dif8C",64,1,95,109,52,6.50,10,5,8
52,"I Ivnitski-Steele, RS Larson, DM Lovato, HM Khawaja, SS Winter, TI Oprea, ...","High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters",2008,"Assay and drug development technologies","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2346768514936259429",82,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:tOudhMTPpwUC",6,2,263,276,52,4.73,7,7,11
52,"DG Lloyd, G Golfis, AJS Knox, D Fayne, MJ Meegan, TI Oprea","Oncology exploration: charting cancer medicinal chemistry space",2006,"Drug discovery today 11 (3-4)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18117033049580662052",83,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:OU6Ihb5iCvQC",,,149,159,52,4.00,9,6,13
50,"EA Ariazi, A Leitao, TI Oprea, B Chen, T Louis, AM Bertucci, CGN Sharma, ...","Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen",2007,"Molecular cancer therapeutics","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8880484620406312924",84,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:u9iWguZQMMsC",6,11,2817,2827,50,4.17,6,8,12
49,"TK Allu, TI Oprea","Rapid evaluation of synthetic and molecular complexity for in silico chemistry",2005,"Journal of chemical information and modeling","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10946848520305737449",85,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:p2g8aNsByqUC",45,5,1237,1243,49,3.50,25,2,14
48,"RS Larson, T Davis, C Bologa, G Semenuk, S Vijayan, Y Li, T Oprea, ...","Dissociation of I Domain and Global Conformational Changes in LFA-1: Refinement of Small Molecule-I Domain Structure− Activity Relationships",2005,"Biochemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13261748453662325040,16378393838550783315",86,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:SP6oXDckpogC",44,11,4322,4331,48,3.43,6,8,14
47,"JW Nilsson, F Thorstensson, I Kvarnström, T Oprea, B Samuelsson, ...","Solid-phase synthesis of libraries generated from a 4-phenyl-2-carboxy-piperazine scaffold",2001,"Journal of combinatorial chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12503672374682078943",87,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:08ZZubdj9fEC",3,6,546,553,47,2.61,8,6,18
45,"DP Hristozov, TI Oprea, J Gasteiger","Virtual screening applications: a study of ligand-based methods and different structure representations in four different scenarios",2007,"Journal of computer-aided molecular design 21 (10-11)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11988297359291569534",88,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:XiSMed-E-HIC",,,617,640,45,3.75,15,3,12
43,"CL Lu, JC Hsieh, NJ Dun, TI Oprea, PS Wang, JC Luo, HC Lin, FY Chang, ...","Estrogen rapidly modulates 5-hydroxytrytophan-induced visceral hypersensitivity via GPR30 in rats",2009,"Gastroenterology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13687424496955447689",89,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:kRWSkSYxWN8C",137,3,1040,1050,43,4.30,5,9,10
43,"MJ Wester, SN Pollock, EA Coutsias, TK Allu, S Muresan, TI Oprea","Scaffold topologies. 2. Analysis of chemical databases",2008,"Journal of chemical information and modeling","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7788626759618819402",90,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:l7t_Zn2s7bgC",48,7,1311,1324,43,3.91,7,6,11
43,"TI Oprea, D Ciubotariu, TI Sulea, Z Simon","Comparison of the minimal steric difference (MTD) and comparative molecular field analysis (CoMFA) methods for analysis of binding of steroids to carrier proteins",1993,"Quantitative Structure‐Activity Relationships","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15235989478992036197",91,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:P5F9QuxV20EC",12,1,21,26,43,1.65,11,4,26
42,"S Wetzel, W Wilk, S Chammaa, B Sperl, AG Roth, A Yektaoglu, S Renner, ...","A Scaffold‐Tree‐Merging Strategy for Prospective Bioactivity Annotation of γ‐Pyrones",2010,"Angewandte Chemie International Edition","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16736660179993104683",92,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:B3FOqHPlNUQC",49,21,3666,3670,42,4.67,5,8,9
41,"SM Young, CM Bologa, D Fara, BK Bryant, JJ Strouse, JB Arterburn, ...","Duplex high‐throughput flow cytometry screen identifies two novel formylpeptide receptor family probes",2009,"Cytometry Part A: The Journal of the International Society for Advancement …","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13458791225908132462",93,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:sSrBHYA8nusC",,,,,41,4.10,6,7,10
37,"CG Bologa, O Ursu, TI Oprea, CE Melançon III, GP Tegos","Emerging trends in the discovery of natural product antibacterials",2013,"Current opinion in pharmacology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16539607216737948156",94,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:EkHepimYqZsC",13,5,678,687,37,6.17,7,5,6
37,"J Mestres, SA Seifert, TI Oprea","Linking Pharmacology to Clinical Reports: Cyclobenzaprine and Its Possible Association With Serotonin Syndrome",2011,"Clinical Pharmacology & Therapeutics","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5876081057249885467",95,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:qjMakFHDy7sC",90,,662,665,37,4.63,12,3,8
37,"BS Edwards, SM Young, MJ Saunders, C Bologa, TI Oprea, RD Ye, ...","High-throughput flow cytometry for drug discovery",2007,"Expert opinion on drug discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8549380336855498764",96,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:XiVPGOgt02cC",2,5,685,696,37,3.08,5,7,12
37,"D Ciubotariu, E Deretey, TI Oprea, T Sulea, Z Simon, L Kurunczi, ...","Multiconformational Minimal Steric Difference. Structure‐Acetylcholinesterase Hydrolysis Rates Relations for Acetic Acid Esters",1993,"Quantitative Structure‐Activity Relationships","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11402046221131597387",97,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:nb7KW1ujOQ8C",12,4,367,372,37,1.42,5,7,26
36,"TI Oprea, CG Bologa, S Brunak, A Campbell, GN Gan, A Gaulton, ...","Unexplored therapeutic opportunities in the human genome",2018,"Nature Reviews Drug Discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8630922721260372480",98,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:scjTk0LcRdsC",17,5,317,317,36,36.00,5,7,1
36,"H Forsman, J Bylund, TI Oprea, A Karlsson, F Boulay, MJ Rabiet, ...","The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third …",2013,"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14247531317064354307",99,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:q3CdL3IzO_QC",1833,8,1914,1923,36,6.00,5,7,6
36,"SS Winter, DM Lovato, HM Khawaja, BS Edwards, ID Steele, SM Young, ...","High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent",2008,"Journal of biomolecular screening","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15161184064805288167",100,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&pagesize=100&citation_for_view=2O0vLx8AAAAJ:V3AGJWp-ZtQC",13,3,185,193,36,3.27,5,7,11
36,"RF Freitas, TI Oprea, CA Montanari","2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L",2008,"Bioorganic & medicinal chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3800602357393655573",101,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:8AbLer7MMksC",16,2,838,853,36,3.27,12,3,11
35,"JJ Strouse, I Ivnitski-Steele, A Waller, SM Young, D Perez, AM Evangelisti, ...","Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters",2013,"Analytical biochemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13545710182783398873",102,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:yB1At4FlUx8C",437,1,77,87,35,5.83,5,7,6
35,"F Briansó, M C Carrascosa, T I Oprea, J Mestres","Cross-pharmacology analysis of G protein-coupled receptors",2011,"Current topics in medicinal chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12575949952495356233",103,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:_B80troHkn4C",11,15,1956,1963,35,4.38,9,4,8
35,"R Burai, C Ramesh, M Shorty, R Curpan, C Bologa, LA Sklar, T Oprea, ...","Highly Efficient Synthesis and Characterization of the GPR30‐Selective Agonist G‐1 and Related Tetrahydroquinoline Analogues.",2010,"Organic & biomolecular chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1872888728493264317",104,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:dhFuZR0502QC",8,9,2252,2259,35,3.89,4,8,9
34,"AA Tica, EC Dun, OS Tica, X Gao, JB Arterburn, GC Brailoiu, TI Oprea, ...","G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium",2011,"American Journal of Physiology-Cell Physiology 301 (5), C1262-C","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7040863050612834277",105,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:L8Ckcad2t8MC",1269,,,,34,4.25,4,8,8
34,"BS Edwards, SM Young, TI Oprea, CG Bologa, ER Prossnitz, LA Sklar","Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform",2006,"Nature protocols","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12209014980485639725",106,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:5Ul4iDaHHb8C",1,1,59,59,34,2.62,6,6,13
33,"SN Pollock, EA Coutsias, MJ Wester, TI Oprea","Scaffold topologies. 1. Exhaustive enumeration up to eight rings",2008,"Journal of chemical information and modeling","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4734720386868230056",107,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:VOx2b1Wkg3QC",48,7,1304,1310,33,3.00,8,4,11
32,"F Broccatelli, E Carosati, G Cruciani, TI Oprea","Transporter‐mediated efflux influences CNS side effects: ABCB1, from antitarget to target",2010,"Molecular informatics 29 (1‐2)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8361095559383275486",108,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:eJXPG6dFmWUC",,,16,26,32,3.56,8,4,9
32,"TI Oprea","On the information content of 2D and 3D descriptors for QSAR",2002,"Journal of the Brazilian Chemical Society","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6920826969813320555",109,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:4fKUyHm3Qg0C",13,6,811,815,32,1.88,32,1,17
31,"JJ Yang, O Ursu, CA Lipinski, LA Sklar, TI Oprea, CG Bologa","Badapple: promiscuity patterns from noisy evidence",2016,"Journal of cheminformatics","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6031975652831740987",110,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:LdasjJ6CEcoC",8,1,29,29,31,10.33,5,6,3
31,"TI Oprea, JP Overington","Computational and Practical Aspects of Drug Repositioning",2015,"Drug Repurposing, Rescue, and Repositioning","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=674795879181842928",111,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:lvd772isFD0C",1,1,,,31,7.75,16,2,4
28,"R Garcia-Serna, O Ursu, TI Oprea, J Mestres","iPHACE: integrative navigation in pharmacological space",2010,"Bioinformatics","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8948590694690196981",112,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:LPZeul_q3PIC",26,7,985,986,28,3.11,7,4,9
28,"MK Haynes, JJ Strouse, A Waller, A Leitao, RF Curpan, C Bologa, ...","Detection of intracellular granularity induction in prostate cancer cell lines by small molecules using the HyperCyt® high-throughput flow cytometry system",2009,"Journal of biomolecular screening","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17566274402509565558",113,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:u5HHmVD_uO8C",14,6,596,609,28,2.80,4,7,10
27,"J Kringelum, SK Kjaerulff, S Brunak, O Lund, TI Oprea, O Taboureau","ChemProt-3.0: a global chemical biology diseases mapping",2016,"Database","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13171069141690118223",114,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:48xauSegjOkC",2016,,,,27,9.00,5,6,3
27,"MJ Saunders, SW Graves, LA Sklar, TI Oprea, BS Edwards","High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors",2010,"Assay and drug development technologies","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10409094248403490928",115,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:JoZmwDi-zQgC",8,1,37,46,27,3.00,5,5,9
27,"DC Fara, TI Oprea, ER Prossnitz, CG Bologa, BS Edwards, LA Sklar","Integration of virtual and physical screening",2006,"Drug Discovery Today: Technologies","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10784951798589840049",116,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:tS2w5q8j5-wC",3,4,377,385,27,2.08,5,6,13
27,"L Kurunczi, E Seclaman, TI Oprea, L Crisan, Z Simon","MTD− PLS: A PLS Variant of the Minimal Topologic Difference Method. III. Mapping Interactions between Estradiol Derivatives and the Alpha Estrogenic Receptor",2005,"Journal of chemical information and modeling","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17360153086711057765",117,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:vRqMK49ujn8C",45,5,1275,1281,27,1.93,5,5,14
27,"T Sulea, TI Oprea, S Muresan, SL Chan","A different method for steric field evaluation in CoMFA improves model robustness",1997,"Journal of chemical information and computer sciences","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10601524170006814608",118,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Tiz5es2fbqcC",37,6,1162,1170,27,1.23,7,4,22
27,"TI Oprea, L Kurunczi, S Timofei","QSAR studies of disperse azo dyes. Towards the negation of the pharmacophore theory of dye-fiber interaction?",1997,"Dyes and pigments","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1217704236154710904",119,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:WbkHhVStYXYC",33,1,41,64,27,1.23,9,3,22
26,"RS Larson, TI Oprea","Bioinformatics and Drug Discovery",2006,"Humana Press","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1938523083021271215",120,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:4sHRCyKql0sC",,,,,26,2.00,13,2,13
26,"CG Bologa, MM Olah, TI Oprea","Chemical database preparation for compound acquisition or virtual screening",2006,"Bioinformatics and Drug Discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7916279484471416046",121,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:eflP2zaiRacC",,,375,388,26,2.00,9,3,13
25,"EA Williamson, L Damiani, A Leitao, C Hu, H Hathaway, T Oprea, L Sklar, ...","Targeting the transposase domain of the DNA repair component Metnase to enhance chemotherapy",2012,"Cancer research","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15799035521910537965",122,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:EYYDruWGBe4C",72,23,6200,6208,25,3.57,3,8,7
25,"D Hristozov, TI Oprea, J Gasteiger","Ligand‐Based Virtual Screening by Novelty Detection with Self‐Organizing Maps.",2007,"Journal of chemical information and modeling","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8467231196522680755",123,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:bEWYMUwI8FkC",47,6,2044,2062,25,2.08,8,3,12
24,"TI Oprea, LA Sklar, JO Agola, Y Guo, M Silberberg, J Roxby, A Vestling, ...","Novel activities of select NSAID R-enantiomers against Rac1 and Cdc42 GTPases",2015,"PloS one","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12621086462393675311",124,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:PVgj2kMGcgYC",10,11,142182,,24,6.00,3,8,4
24,"DT Manallack, RJ Prankerd, GC Nassta, O Ursu, TI Oprea, DK Chalmers","A chemogenomic analysis of ionization constants—implications for drug discovery",2013,"ChemMedChem","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3750699998730528899",125,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Fu2w8maKXqMC",8,2,242,255,24,4.00,4,6,6
23,"E Deliu, GC Brailoiu, JB Arterburn, TI Oprea, K Benamar, NJ Dun, ...","Mechanisms of G protein-coupled estrogen receptor-mediated spinal nociception",2012,"The Journal of Pain","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5623908923541088735",126,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:ye4kPcJQO24C",13,8,742,754,23,3.29,3,7,7
23,"RF Curpan, PC Simons, D Zhai, SM Young, MB Carter, CG Bologa, ...","High-throughput screen for the chemical inhibitors of antiapoptotic bcl-2 family proteins by multiplex flow cytometry",2011,"Assay and drug development technologies","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5725545380837523507",127,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:WF5omc3nYNoC",9,5,465,474,23,2.88,3,7,8
22,"LZ Benet, CM Hosey, O Ursu, TI Oprea","BDDCS, the rule of 5 and drugability",2016,"Advanced drug delivery reviews","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14329585898360946985",128,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:kVjdVfd2voEC",101,,89,98,22,7.33,6,4,3
22,"I Kouskoumvekaki, RK Petersen, F Fratev, O Taboureau, TE Nielsen, ...","Discovery of a Novel Selective PPARγ Ligand with Partial Agonist Binding Properties by Integrated in Silico/in Vitro Work Flow",2013,"Journal of chemical information and modeling","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7380303582995416298",129,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:vbGhcppDl1QC",53,4,923,937,22,3.67,4,6,6
22,"O Ursu, TI Oprea","Model-free drug-likeness from fragments",2010,"Journal of chemical information and modeling","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6041247431391309325",130,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:bnK-pcrLprsC",50,8,1387,1394,22,2.44,11,2,9
22,"KH Baringhaus, H Matter, T Oprea","Efficient strategies for lead optimization by simultaneously addressing affinity, selectivity and pharmacokinetic parameters",2004,"Chemoinformatics in Drug Discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9333431852143205256",131,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:jU7OWUQzBzMC",,,333,379,22,1.47,7,3,15
21,"Y Guo, SR Kenney, L Cook, SF Adams, T Rutledge, E Romero, TI Oprea, ...","A novel pharmacologic activity of ketorolac for therapeutic benefit in ovarian cancer patients",2015,"Clinical Cancer Research","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4783733255212949755",132,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:AHdEip9mkN0C",21,22,5064,5072,21,5.25,3,8,4
21,"K Önnheim, K Christenson, M Gabl, JC Burbiel, CE Müller, TI Oprea, ...","A novel receptor cross-talk between the ATP receptor P2Y2 and formyl peptide receptors reactivates desensitized neutrophils to produce superoxide",2014,"Experimental cell research","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8256016244126436003",133,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:9c2xU6iGI7YC",323,1,209,217,21,4.20,3,7,5
21,"BH Njus, A Chigaev, A Waller, D Wlodek, L Ostopovici-Halip, O Ursu, ...","Conformational mAb as a tool for integrin ligand discovery",2009,"Assay and drug development technologies","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15552058591098194880",134,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:eMMeJKvmdy0C",7,5,507,515,21,2.10,3,7,10
21,"TI Oprea, CG Bologa, BS Edwards, ER Prossnitz, LA Sklar","Post-high-throughput screening analysis: an empirical compound prioritization scheme",2005,"Journal of biomolecular screening","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3386675154682274171",135,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:geHnlv5EZngC",10,5,419,426,21,1.50,4,5,14
21,"I Zamora, TI Oprea, AL Ungell","Prediction of oral drug permeability",2001,"Rational approaches to drug design","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18354696051122208150",136,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:fQNAKQ3IYiAC",,,271,280,21,1.17,7,3,18
21,"TI Oprea, CMW Ho, GR Marshall","De novo design: ligand construction and prediction of affinity",1995,"ACS Symposium Series","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6454007569409646697,662989973298936360,444177500104764883,1569858209820426481",137,"2019-05-16","Conference paper","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:t6usbXjVLHcC",589,,64,81,21,0.88,7,3,24
20,"JB Arterburn, TI Oprea, ER Prossnitz, BS Edwards, LA Sklar","Discovery of Selective Probes and Antagonists for G Protein-Coupled Receptors FPR/FPRL1 and GPR30",2009,"Current topics in medicinal chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12585241776910713889",138,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:2osOgNQ5qMEC",9,13,1227,1236,20,2.00,4,5,10
20,"L Peltason, J Bajorath","Molecular similarity analysis in virtual screening",2008,"Chemoinformatics Approaches to Virtual Screening","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=943523409477192237,168182069188529377",139,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:buQ7SEKw-1sC",,,182,216,20,1.82,10,2,11
20,"L Kurunczi, M Olah, TI Oprea, C Bologa, Z Simon","MTD-PLS: A PLS-Based Variant of the MTD Method. 2. Mapping Ligand− Receptor Interactions. Enzymatic Acetic Acid Esters Hydrolysis",2002,"Journal of chemical information and computer sciences","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8883719745021086010,12979663222555396024",140,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:q3oQSFYPqjQC",42,4,841,846,20,1.18,4,5,17
19,"A De Souza, JA Bittker, DL Lahr, S Brudz, S Chatwin, TI Oprea, A Waller, ...","An overview of the challenges in designing, integrating, and delivering BARD: a public chemical-biology resource and query portal for multiple organizations, locations, and …",2014,"Journal of biomolecular screening","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13937487246602764115",141,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:IRz6iEL74y4C",19,5,614,627,19,3.80,2,8,5
19,"JJ Strouse, I Ivnitski-Steele, HM Khawaja, D Perez, J Ricci, T Yao, ...","A selective ATP-binding cassette subfamily G member 2 efflux inhibitor revealed via high-throughput flow cytometry",2013,"Journal of biomolecular screening","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10443346817657355341",142,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:oNZyr7d5Mn4C",18,1,26,38,19,3.17,3,7,6
19,"TI Oprea, L Kurunczi, M Olah, Z Simon","MTD-PLS: A PLS-based variant of the MTD method. A 3D-QSAR analysis of receptor affinities for a series of halogenated dibenzoxin and biphenyl derivatives",2001,"SAR and QSAR in Environmental Research 12 (1-2)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5799585785176733500",143,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:D_sINldO8mEC",,,75,92,19,1.06,5,4,18
18,"AMG Thompson, O Ursu, P Babkin, CV Iancu, A Whang, TI Oprea, J Choe","Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation",2016,"Scientific reports","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6667329009354308582",144,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:U4n9YNQMCAIC",6,,24240,24240,18,6.00,3,7,3
18,"SL Mathias, J Hines-Kay, JJ Yang, G Zahoransky-Kohalmi, CG Bologa, ...","The CARLSBAD database: a confederated database of chemical bioactivities",2013,"Database","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11375726011139084702",145,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:kuK5TVdYjLIC",2013,,,,18,3.00,3,6,6
18,"TI Oprea, EE May, A Leitão, A Tropsha","Computational systems chemical biology",2011,"Chemoinformatics and Computational Chemical Biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13758954866183308569",146,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:blknAaTinKkC",,,459,488,18,2.25,5,4,8
17,"GJ Myatt, E Ahlberg, Y Akahori, D Allen, A Amberg, LT Anger, A Aptula, ...","In silico toxicology protocols",2018,"Regulatory Toxicology and Pharmacology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2976947502030869109",147,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:c0d25C_dN_AC",96,,1,17,17,17.00,2,8,1
17,"PR Hall, A Leitão, C Ye, K Kilpatrick, B Hjelle, TI Oprea, RS Larson","Small molecule inhibitors of hantavirus infection",2010,"Bioorganic & medicinal chemistry letters","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13700905621828285185",148,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:UebtZRa9Y70C",20,23,7085,7091,17,1.89,2,7,9
17,"C Bologa, TK Allu, M Olah, MA Kappler, TI Oprea","Descriptor collision and confusion: Toward the design of descriptors to mask chemical structures",2005,"Journal of computer-aided molecular design 19 (9-10)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11468422425954093991",149,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:tkaPQYYpVKoC",,,625,635,17,1.21,3,5,14
16,"GC Brailoiu, JB Arterburn, TI Oprea, VC Chitravanshi, E Brailoiu","Bradycardic effects mediated by activation of G protein‐coupled estrogen receptor in rat nucleus ambiguus",2013,"Experimental physiology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9235242469667062030",150,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:evX43VCCuoAC",98,3,679,691,16,2.67,3,5,6
16,"H Çevik-Aras, C Kalderén, AJ Jensen, T Oprea, C Dahlgren, H Forsman","A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1",2012,"Biochemical pharmacology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1496990018479226550",151,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:UHK10RUVsp4C",83,12,1655,1662,16,2.29,3,6,7
16,"IV Tetko, R Abagyan, TI Oprea","Surrogate data–a secure way to share corporate data",2005,"Journal of computer-aided molecular design 19 (9-10)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9776480978251912758",152,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:9vf0nzSNQJEC",,,749,764,16,1.14,5,3,14
16,"TI Oprea","Rapid estimation of hydrophobicity for virtual combinatorial library analysis",2001,"SAR and QSAR in Environmental Research 12 (1-2)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15471597398855927666",153,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:BrmTIyaxlBUC",,,129,141,16,0.89,16,1,18
14,"T Sulea, L Kurunczi, TI Oprea, Z Simon","MTD-ADJ: A multiconformational minimal topologic difference for determining bioactive conformers using adjusted biological activities",1998,"Journal of computer-aided molecular design","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10657064476477191047",154,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:HE397vMXCloC",12,2,133,146,14,0.67,4,4,21
13,"Y Lin, S Mehta, H Küçük-McGinty, JP Turner, D Vidovic, M Forlin, A Koleti, ...","Drug target ontology to classify and integrate drug discovery data",2017,"Journal of biomedical semantics","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1131901739692800140",155,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:3NQIlFlcGxIC",8,1,50,50,13,6.50,2,8,2
13,"TI Oprea","Chemoinformatics and the quest for leads in drug discovery",2003,"Handbook of Chemoinformatics: From Data to Knowledge in 4 Volumes","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8826569259919988933",156,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Y5dfb0dijaUC",,,1508,1531,13,0.81,13,1,16
13,"TI Oprea, J Gottfries","ChemGPS: A chemical space navigation tool",2001,"Rational Approaches to Drug Design","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2831447443178101170",157,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:hMod-77fHWUC",437,,,,13,0.72,7,2,18
12,"M Gabl, M Winther, A Welin, A Karlsson, T Oprea, J Bylund, C Dahlgren, ...","P2Y2 receptor signaling in neutrophils is regulated from inside by a novel cytoskeleton-dependent mechanism",2015,"Experimental cell research","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16858169700936762514",158,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:sJsF-0ZLhtgC",336,2,242,252,12,3.00,2,8,4
12,"TI Oprea, M Olah, L Ostopovici, R Rad, M Mracec","On the propagation of errors in the QSAR literature",2002,"EuroQSAR 2002 - Designing Drugs and crop protectants: processes, problems …","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11234598562399837504",159,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Mojj43d5GZwC",,,,,12,0.71,2,5,17
11,"M Gabl, A Holdfeldt, M Winther, T Oprea, J Bylund, C Dahlgren, ...","A pepducin designed to modulate P2Y2R function interacts with FPR2 in human neutrophils and transfers ATP to an NADPH-oxidase-activating ligand through a receptor cross-talk …",2016,"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12374438953070783516",160,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:zCSUwVk65WsC",1863,6,1228,1237,11,3.67,2,7,3
11,"A Chigaev, Y Smagley, MK Haynes, O Ursu, CG Bologa, L Halip, T Oprea, ...","FRET detection of lymphocyte function–associated antigen-1 conformational extension",2015,"Molecular biology of the cell","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17562731324143805256",161,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:a3BOlSfXSfwC",26,1,43,54,11,2.75,1,8,4
11,"A Welin, H Björnsdottir, M Winther, K Christenson, T Oprea, A Karlsson, ...","CFP-10 from Mycobacterium tuberculosis selectively activates human neutrophils through a pertussis toxin-sensitive chemotactic receptor",2015,"Infection and immunity","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11652382135492543210",162,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:yqoGN6RLRZoC",83,1,205,213,11,2.75,2,7,4
11,"M Winther, M Gabl, TI Oprea, B Jönsson, F Boulay, J Bylund, C Dahlgren, ...","Antibacterial activity of pepducins, allosterical modulators of formyl peptide receptor signaling",2014,"Antimicrobial agents and chemotherapy","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15311640776472280626",163,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:4vMrXwiscB8C",58,5,2985,2988,11,2.20,1,8,5
11,"K Polireddy, MMT Khan, H Chavan, S Young, X Ma, A Waller, M Garcia, ...","A novel flow cytometric HTS assay reveals functional modulators of ATP binding cassette transporter ABCB6",2012,"PloS one","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10140895716410746001",164,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:N5tVd3kTz84C",7,7,40005,,11,1.57,1,8,7
11,"Z Surviladze, O Ursu, F Miscioscia, R Curpan, L Halip, C Bologa, T Oprea, ...","Three small molecule pan activator families of Ras-related GTPases",2010,"Probe Reports from the NIH Molecular Libraries Program [Internet]","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9566265048956255057",165,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:ufrVoPGSRksC",,,,,11,1.22,1,8,9
11,"TI Oprea, JM Blaney","Cheminformatics approaches to fragment-based lead discovery",2006,"Fragment-based approaches in drug discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10708235961877791677",166,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:WA5NYHcadZ8C",34,,,,11,0.85,6,2,13
0,"TI Oprea","Chemoinformatics in lead discovery",2004,"Chemoinformatics in drug discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10971470759673471693",167,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:dQ2og3OwTAUC",,,25,38,0,0.00,0,1,15
10,"DR Christianson, AS Dobroff, B Proneth, AJ Zurita, A Salameh, ...","Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis",2015,"Proceedings of the National Academy of Sciences","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11903022897738545218",168,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:5MTHONV0fEkC",112,8,2521,2526,10,2.50,2,6,4
10,"TI Oprea, O Taboureau, CG Bologa","Of possible cheminformatics futures",2012,"Journal of computer-aided molecular design","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=783826318497738681",169,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Zph67rFs4hoC",26,1,107,112,10,1.43,3,3,7
10,"M Olah, TI Oprea","Bioactivity databases",2007,"Elsevier","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15855422771349154971",170,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:5awf1xo2G04C",,,,,10,0.83,5,2,12
10,"I McFayden, G Walker, J Alvarez","Enhancing hit quality and diversity within assay throughput constraints",2004,"Chemoinformatics in Drug Discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8023183996677525476",171,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Ak0FvsSvgGUC",,,143,173,10,0.67,3,3,15
10,"TI Oprea","Qvo Vadis, Scoring Functions? Toward an Integrated Phannacokinetic and Binding Affinity Prediction Framework",2001,"Combinatorial Library Design and Evaluation","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7663448976123573317",172,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:olpn-zPbct0C",,,253,286,10,0.56,10,1,18
9,"PD Leeson, TI Oprea","Drug-like physicochemical properties",2011,"Drug Design Strategies","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3466642975855898774",173,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:isC4tDSrTZIC",,,35,59,9,1.13,5,2,8
9,"ER Prossnitz, JB Arterburn, BS Edwards, LA Sklar, TI Oprea","Steroid-binding G-protein-coupled receptors: new drug discovery targets for old ligands",2006,"Expert opinion on drug discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12835656588676918846",174,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:zYLM7Y9cAGgC",1,2,137,150,9,0.69,2,5,13
8,"TA Thompson, D Mackenzie, TI Oprea, LA Sklar, BS Edwards, M Haynes","Methods and related compositions for the treatment of cancer",2014,"US Patent 8","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17681261945796029130,5407687128423256117",175,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:mB3voiENLucC",835,,506,506,8,1.60,1,6,5
8,"EE May, A Leitão, A Tropsha, TI Oprea","A systems chemical biology study of malate synthase and isocitrate lyase inhibition in Mycobacterium tuberculosis during active and NRP growth",2013,"Computational biology and chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11320692945923172407",176,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:VLnqNzywnoUC",47,,167,180,8,1.33,2,4,6
8,"C Custodi, R Nuti, TI Oprea, A Macchiarulo","Fitting the complexity of GPCRs modulation into simple hypotheses of ligand design",2012,"Journal of Molecular Graphics and Modelling","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4404050392430584852",177,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:zLWjf1WUPmwC",38,,70,81,8,1.14,2,4,7
8,"J Gottfries, T Oprea","Global method for mapping property spaces",2004,"US Patent 6","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13127081319889060164,14406731224144707799",178,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:kNdYIx-mwKoC",675,,136,136,8,0.53,4,2,15
7,"YC Martin, R Abagyan, GG Ferenczy, VJ Gillet, TI Oprea, J Ulander, ...","Glossary of terms used in computational drug design, part II (IUPAC Recommendations 2015)",2016,"Pure and Applied Chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7495509662778952842",179,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:lgwcVrK6X84C",88,3,239,264,7,2.33,1,7,3
7,"SM Bernardo, CP Allen, A Waller, SM Young, T Oprea, LA Sklar, SA Lee","An automated high-throughput cell-based multiplexed flow cytometry assay to identify novel compounds to target Candida albicans virulence-related proteins",2014,"PloS one","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14710567098091454536",180,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:LhH-TYMQEocC",9,10,110354,,7,1.40,1,7,5
7,"S Wetzel, K Klein, S Renner, D Rauh, TI Oprea, P Mutzel, H Waldmann","Corrigendum: Interactive exploration of chemical space with Scaffold Hunter",2009,"Nature Chemical Biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=383277227828197304",181,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:VL0QpB8kHFEC",5,9,696,696,7,0.70,1,7,10
6,"B S Edwards, K Gouveia, T I Oprea, L A Sklar","The University of New Mexico Center for Molecular Discovery",2014,"Combinatorial chemistry & high throughput screening","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15465253303459089303",182,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:WJVC3Jt7v1AC",17,3,256,265,6,1.20,2,4,5
6,"CG Bologa, TI Oprea","Compound collection preparation for virtual screening",2012,"Bioinformatics and Drug Discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5210260663203238530",183,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:-FonjvnnhkoC",,,125,143,6,0.86,3,2,7
6,"M Pastor, P Benedetti, A Carotti, A Carrieri, C Diaz, C Herraiz, HD Höltje, ...","Distant collaboration in drug discovery: The LINK3D project",2002,"Journal of computer-aided molecular design","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9510214319959531801",184,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:UeHWp8X0CEIC",16,11,809,818,6,0.35,1,8,17
6,"L Giosan, T Oprea","Science in post-communist Romania",2002,"Ad Astra","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2576565891746301056,17940227047456183302",185,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:JQOojiI6XY0C",1,2,,,6,0.35,3,2,17
6,"CS Tung, TI Oprea, G Hummer, AE Garcia","Three‐dimensional model of a selective theophylline‐binding RNA molecule",1996,"Journal of Molecular Recognition: An Interdisciplinary Journal","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3915292767326824237",186,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:u-x6o8ySG0sC",9,4,275,286,6,0.26,2,4,23
6,"TI Oprea, RD Head, GR Marshall","The basis of cross-reactivity for a series of steroids binding to a monoclonal antibody against progesterone (DB3): A molecular modeling and QSAR study",1995,"QSAR and Molecular Modelling: Concepts, Computational Tools and Biological …","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4856480544592401019",187,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:SdhP9T11ey4C",,,,,6,0.25,2,3,24
5,"A Wandinger-Ness, L Sklar, Z Surviladze, T Oprea, L Hudson, J Aube, ...","Modulators of GTPase and use in relevant treatment",2017,"US Patent 9","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9035416717520601590",188,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:DUooU5lO8OsC",642,,835,835,5,2.50,1,7,2
5,"G Zahoránszky-Kőhalmi, CG Bologa, TI Oprea","Impact of similarity threshold on the topology of molecular similarity networks and clustering outcomes",2016,"Journal of cheminformatics","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13719053448981823232",189,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:43bX7VzcjpAC",8,1,16,16,5,1.67,2,3,3
5,"JJ Strouse, I Ivnitski-Steele, HM Njus, TD Foutz, T Yao, WS Weiner, ...","Selective efflux inhibition of ATP-binding cassette sub-family G member 2",2013,"Probe Reports from the NIH Molecular Libraries Program [Internet]","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3775856246741201988",190,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:BwyfMAYsbu0C",,,,,5,0.83,1,7,6
5,"ER Prossnitz, SE Tkatchenko, CM Revankar, LA Sklar, JB Arterburn, ...","Compounds for binding to ERα/β and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof",2011,"US Patent 7","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4593019202111010710",191,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:4TOpqqG69KYC",875,,721,721,5,0.63,1,6,8
5,"E May, A Leitao, JL Faulon, J Joo, M Misra, TI Oprea","Understanding virulence mechanisms in M. tuberculosis infection via a circuit-based simulation framework",2008,"2008 30th Annual International Conference of the IEEE Engineering in …","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12581704114426542601",192,"2019-05-16","Conference paper","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Se3iqnhoufwC",,,,,5,0.45,1,6,11
5,"WM Brown, A Sasson, DR Bellew, LA Hunsaker, S Martin, A Leitao, ...","Efficient calculation of molecular properties from simulation using kernel molecular dynamics",2008,"Journal of chemical information and modeling","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18049280565736729587",193,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Y0pCki6q_DkC",48,8,1626,1637,5,0.45,1,7,11
5,"R RAD, M Mracec, M Mraceca, T Oprea","The privileged structures hypothesis for G protein-coupled receptors-some preliminary results",2007,"Revue Roumaine de Chimie 52 (8-9), 853-+","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2608821711704424487",194,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:gsN89kCJA0AC",,,,,5,0.42,1,4,12
5,"M OPREA","Muntele lui Venus",2002,"Eurostampa","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14235584443741432803",195,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:eq2jaN3J8jMC",,,,,5,0.29,5,1,17
5,"TI Oprea, AT Balaban","De veghe în cercetarea românească",2001,"Mirton","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9403495120457819943",196,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:OR75R8vi5nAC",,,,,5,0.28,3,2,18
4,"DC Cannon, JJ Yang, SL Mathias, O Ursu, S Mani, A Waller, SC Schürer, ...","TIN-X: target importance and novelty explorer",2017,"Bioinformatics","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7949605575265336171",197,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:LPtt_HFRSbwC",33,16,2601,2603,4,2.00,1,8,2
4,"JJ Yang, O Ursu, CG Bologa, A Waller, LA Sklar, TI Oprea","BADAPPLE promiscuity plugin for BARD: Evidence-based promiscuity scores",2013,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12978397849054585807",198,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:_Nt1UvVys9QC",246,,,,4,0.67,1,6,6
4,"TI Oprea, MA Kappler, TK Allu, M Mracec, MM Olah, R Rad, L Ostopovici, ...","QSAR and Molecular Modelling in Rational Design of Bioactive Molecules",2006,"Computer Aided Drug Design & Development Society in Turkey","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4402802554601518296",199,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:_Ybze24A_UAC",,,,,4,0.31,1,8,13
4,"TI Oprea, P Benedetti, G Berellini, M Olah, K Fejgin, S Boyer","Rapid ADME filters for lead discovery",2005,"Molecular Interaction Fields: Applications in Drug Discovery and ADME …","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2393053315356515151",200,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=100&pagesize=100&citation_for_view=2O0vLx8AAAAJ:3fE2CSJIrl8C",,,,,4,0.29,1,6,14
3,"R Vazquez Guillamet, O Ursu, G Iwamoto, PL Moseley, T Oprea","Chronic obstructive pulmonary disease phenotypes using cluster analysis of electronic medical records",2018,"Health informatics journal","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2956362661887429948",201,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:MhiOAD_qIWkC",24,4,394,409,3,3.00,1,5,1
3,"KAL Collins, TJ Stuhlmiller, JS Zawistowski, MP East, TT Pham, CR Hall, ...","Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer",2018,"Oncotarget","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11883954953377870247",202,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:rv71eUSj1K8C",9,21,15480,15480,3,3.00,0,7,1
3,"MK Haynes, M Garcia, R Peters, A Waller, P Tedesco, O Ursu, CG Bologa, ...","High-Throughput Flow Cytometry Screening of Multidrug Efflux Systems",2018,"Bacterial Multidrug Exporters","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15349022685801410537",203,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:8bEfNjzhQ0EC",,,293,318,3,3.00,0,8,1
3,"SJ Nelson, TI Oprea, O Ursu, CG Bologa, A Zaveri, J Holmes, JJ Yang, ...","Formalizing drug indications on the road to therapeutic intent",2017,"Journal of the American Medical Informatics Association","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11153434399570237103",204,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:_UIRw3K-QSMC",24,6,1169,1172,3,1.50,0,8,2
3,"J Chen, SM Young, C Allen, A Waller, O Ursu, JJ Strouse, T Yao, ...","Profiling a selective probe for RTG branch of yeast TORC1 signaling pathway",2013,"Probe Reports from the NIH Molecular Libraries Program [Internet]","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9879819067045496748",205,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:5qfkUJPXOUwC",,,,,3,0.50,0,8,6
3,"TI Oprea","Sense and nonsense in drug discovery: a chemical perspective",2008,"Towards Drugs of the Future: Key Issues in Lead Finding and Lead …","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16610271417716574074,10998697841937913266",206,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:r0BpntZqJG4C",,,,,3,0.27,3,1,11
3,"TI Oprea, A Tropsha","Cheminformatics and drug discovery",2006,"Drug Discovery Today: Technologies","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3158479848391804885",207,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:iH-uZ7U-co4C",4,3,355,356,3,0.23,2,2,13
3,"CMW Ho","In silico lead optimization",2004,"Chemoinformatics in Drug Discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=906394531352105948",208,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:otzGkya1bYkC",,,199,219,3,0.20,3,1,15
3,"TI Oprea, M Baroni, I Zamora, G Cruciani","High throughput prediction of passive ADME properties from fragments.",2002,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 224, U485-U","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=791219012780879856",209,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:SuREjsGmJT0C",485,,,,3,0.18,1,4,17
3,"A Chiriac","Quantum Biochemistry and Specific Interactions: The QSAR and Quantum Chemistry Group of Timisoara",2002,"Mirton","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5846165339026634992",210,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:_OXeSy2IsFwC",,,,,3,0.18,3,1,17
3,"TI Oprea","Pursuing leadlikeness in pharmaceutical research",2001,"navigation","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11518467102216801090",211,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:sFh2DmJudxsC",4,,258,266,3,0.17,3,1,18
3,"GR Marshall, CMW Ho, RD Head, ML Smythe, TI Oprea, CL Waller, ...","3D QSAR and de novo design: choosing the appropriate tools",1995,"QSAR and Molecular Modeling: Concepts, Computational Tools and Biological …","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=406629762794436168",212,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:kzcrU_BdoSEC",,,,,3,0.13,0,7,24
3,"L Kurunczi, TI Sulea, TI Oprea","Conformational analysis and experimental dipole moments: a study of furan derivatives",1994,"Journal of Molecular Structure: THEOCHEM 306 (2-3)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10908686623109617837",213,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:LkGwnXOMwfcC",,,93,100,3,0.12,1,3,25
3,"TI Oprea, CL Waller, GR Marshall","Viral proteases: Structure and function",1994,"Modern Cell Biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6039192283651030526",214,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:0EnyYjriUFMC",15,,183,183,3,0.12,1,3,25
2,"T Liu, T Oprea, O Ursu, C Hasselgren, RB Altman","Estimation of maximum recommended therapeutic dose using predicted promiscuity and potency",2016,"Clinical and translational science","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2142807777852494947",215,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:IaI1MmNe2tcC",9,6,311,320,2,0.67,0,5,3
2,"AS Dobroff, R Rangel, L Guzman‐Roja, CC Salmeron, JG Gelovani, ...","Ligand‐Directed Profiling of Organelles with Internalizing Phage Libraries",2015,"Current protocols in protein science 79 (1), 30.4. 1-30.4.","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16076667818626673542",216,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:u-coK7KVo8oC",30,,,,2,0.50,0,6,4
2,"Y Guo, SR Kenney, E Romero, T Oprea, S Adams, C Muller, L Sklar, ...","Abstract B81: Selected NSAIDs target GTPases for ovarian cancer therapy",2013,"Clinical Cancer Research 19 (19 Supplement), B81-B","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9626619379560510801",217,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:3htObqc8RwsC",81,,,,2,0.33,0,8,6
2,"J Zou, R Ardecky, AB Pinkerton, E Sergienko, Y Su, D Stonich, RF Curpan, ...","Selective Bcl-2 Inhibitor Probes",2013,"Probe Reports from the NIH Molecular Libraries Program [Internet]","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8393814536887758762",218,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:j8SEvjWlNXcC",,,,,2,0.33,0,8,6
2,"M Mracec, TI Oprea, M Mracec","Models of the algistatic activity of 5-amino-1-aryl-1H-tetrazoles",2011,"Rev Roum Chim","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11662065336517205804",219,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:hFOr9nPyWt4C",56,4,373,379,2,0.25,1,3,8
2,"SR Kenney, J Roxby, E Romero, O Ursu, T Oprea, L Sklar, ...","Enantiomer specific inhibition of Rac1 and Cdc42 in ovarian cancer",2011,"MOLECULAR BIOLOGY OF THE CELL","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1654408942155586710",220,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:lmc2jWPfTJgC",22,,,,2,0.25,0,7,8
2,"DC Fara, TI Oprea","Cheminformatics-Basics: Molecular Descriptors and Fingerprints",2011,"","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13261591586705001585",221,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:XD-gHx7UXLsC",,,,,2,0.25,1,2,8
2,"TI Oprea, L Ostopovici-Halip, R Rad-Curpan","Databases for chemical and biological information",2010,"Pharmaceutical data mining. Wiley, Hoboken, NJ","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7648035305666197531",222,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:qUcmZB5y_30C",,,491,520,2,0.22,1,3,9
2,"D MacKenzie, M Haynes, CA Hu, L Skalr, T Oprea, C Bologa, ...","High-throughput screening of small molecule inducers of autophagy as potential therapies for prostate cancer",2009,"CANCER RESEARCH","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2701625956734322959",223,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:cK4Rrx0J3m0C",69,,,,2,0.20,0,7,10
1,"O Ursu, J Holmes, CG Bologa, JJ Yang, SL Mathias, V Stathias, ...","DrugCentral 2018: an update",2018,"Nucleic acids research 47 (D1), D963-D","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18442233969733237714",224,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:nrS8eym_YfUC",970,,,,1,1.00,0,7,1
1,"CC Palsuledesai, Z Surviladze, A Waller, TF Miscioscia, Y Guo, Y Wu, ...","Activation of Rho Family GTPases by Small Molecules",2018,"ACS chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16355969322980777252",225,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:gAJFiZdMcUIC",13,6,1514,1524,1,1.00,0,7,1
1,"Q Cheng, O Ursu, TI Oprea, S Schurer","Learning reference-enriched approach towards large scale active ontology alignment and integration",2017,"2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7276152592991386900",226,"2019-05-16","Conference paper","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Mr27SXpvooAC",,,,,1,0.50,0,4,2
1,"Q Cheng, FA Lopez, C Duran, C Camarillo, TI Oprea, S Schurer","The ontology reference model for visual selectivity analysis in drug-target interactions",2017,"2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2008038316769319852",227,"2019-05-16","Conference paper","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:T4xR6ACgc60C",,,,,1,0.50,0,6,2
1,"TI Oprea, C Hasselgren","Predicting target and chemical druggability",2017,"Elsevier","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10325422845746236626",228,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:vtskfw0NoLIC",,,,,1,0.50,1,2,2
1,"AW Ness, L Hudson, L Sklar, Z Surviladze, T Oprea","Modulators of GTPases and their use",2015,"US Patent 9","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2052630584647025279,18208007645412908587",229,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:0CzhzZyukY4C",125,,899,899,1,0.25,0,5,4
1,"Y Guo, SR Kenney, LA Sklar, T Buranda, TI Oprea, O Ursu, SF Adams, ...","R-ketorolac targets Cdc42 and Rac1 GTPases and alters ovarian tumor cell behaviors critical for invasion and metastasis",2015,"Cancer Research 75 (15 Supplement)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7267975680653716851",230,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:6yz0xqPARnAC",4044,,,,1,0.25,0,8,4
1,"A Ioannidis, M Magana, CG Bologa, TI Oprea, IT Paulsen, GP Tegos","Defining the microbial effluxome in the content of the host-microbiome interaction",2015,"Frontiers in pharmacology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11054853787426716468",231,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:fbc8zXXH2BUC",6,,31,31,1,0.25,0,6,4
1,"A Welin, H Björnsdottir, M Winther, K Christenson, T Oprea, A Karlsson, ...","Culture filtrate protein 10 kDa (CFP-10) from Mycobacterium tuberculosis selectively activates human neutrophils through a pertussis toxin-sensitive chemotactic receptor",2014,"Infection and Immunity, IAI.","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6063182262066951450",232,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:MagRZZew-58C",,,2493,14,1,0.20,0,7,5
1,"ER Prossnitz, SE Tkatchenko, CM Revankar, LA Sklar, JB Arterburn, ...","Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof",2013,"US Patent 8","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16933857793979405664",233,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:TAkmkrPVePIC",487,,100,100,1,0.17,0,6,6
1,"SR Kenney, T Oprea, O Ursu, L Sklar, L Lomo, C Muller, Y Gao, ...","Selective inhibition of Rac1 and Cdc42 in ovarian cancer using the R-enantiomer of ketorolac",2012,"Cancer Research 72 (8 Supplement)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9779022422715636801",234,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:P7Ujq4OLJYoC",910,,,,1,0.14,0,8,7
1,"TI Oprea","WOMBAT and WOMBAT-PK: Ten years",2012,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16298091371777301068",235,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:adgdM4TzidAC",243,,,,1,0.14,1,1,7
1,"PD Leeson, TI Oprea","Drug Design Strategies: Quantitative Approaches",2012,"The Royal Society of Chemistry","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15064428299246354905",236,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:VoB_afVdn6EC",,,,,1,0.14,1,2,7
1,"TI Oprea","Next‐generation QSAR",2011,"Molecular informatics 30 (2‐3)","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13697263671602798351",237,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:R3hNpaxXUhUC",89,,,,1,0.13,1,1,8
1,"RS Larson, LA Sklar, BS Edwards, ID Ivnitski-Steele, TI Oprea, DM Lovato, ...","Compounds and methods for the selective inhibition of ABCB1, ABCC1 and ABCG2 transporters and the treatment of cancers, especially drug resistant cancers and high throughput …",2009,"US Patent App. 12","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14413768298912793165",238,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:4DMP91E08xMC",315,,132,132,1,0.10,0,7,10
1,"MJ Wester, SN Pollock, EA Coutsias, TK Allu, S Muresan, TI Oprea","Topological Analysis of Molecular Scaffolds 2: Evolution of Chemical Databases",2007,"Preprint","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7186548722159752600",239,"2019-05-16","Preprint","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:n35PH7pn8T4C",,,,,1,0.08,0,6,12
1,"TI Oprea","Chemoinformatics in Lead Discovery",2006,"Chemoinformatics in Drug Discovery","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9852502029228112170",240,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:sJRvXmEhuqoC",23,,,,1,0.08,1,1,13
1,"LA Sklar, PC Simons, A Waller, SM Biggs, SM Young, M Olah, C Bologa, ...","High‐Throughput Flow Cytometry",2005,"Drug Discovery Handbook","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1761464924415350818",241,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:jhmUvTrEinIC",,,185,226,1,0.07,0,8,14
1,"TI Oprea, M Olah, M Mracec, R Rad, L Ostopovici, A Bora, N Hadaruga, ...","Mapping bioactivity space for fragment-based lead discovery",2005,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 229, U157-U","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16873842934635637236",242,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:r0s_y6AIs4IC",157,,,,1,0.07,0,8,14
1,"T Oprea","Next-generation therapeutics",2004,"Current opinion in Chemical biology","","","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1068130010892376226",243,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:MXK_kJrjxJIC",4,8,347,348,1,0.07,1,1,15
0,"A Nestsiarovich, B Kerner, AJ Mazurie, DC Cannon, NG Hurwitz, Y Zhu, ...","Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacy",2019,"Journal of affective disorders","","","",244,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:bxNerZLeg9kC",252,,201,211,0,0.00,0,7,1
0,"V Păunescu, M Zavolan, T Oprea","In memoriam: Francisc Schneider (1933‐2017)",2019,"Journal of cellular and molecular medicine","","","",245,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Qwfv3SoyJx4C",23,4,3045,3045,0,0.00,0,3,1
0,"O Ursu, M Glick, T Oprea","Novel drug targets in 2018.",2019,"Nature reviews. Drug discovery","","","",246,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:BbFSz4cl-9EC",,,,,0,0.00,0,3,1
0,"CG Bologa, O Ursu, TI Oprea","How to Prepare a Compound Collection Prior to Virtual Screening",2019,"Bioinformatics and Drug Discovery","","","",247,"2019-05-16","Book chapter","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:yNohvu9kXXYC",,,119,138,0,0.00,0,3,1
0,"TI Oprea, L Jan, GL Johnson, BL Roth, A Ma’ayan, S Schürer, ...","Far away from the lamppost",2018,"PLoS biology","","","",248,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:lD5Rj62EkMEC",16,12,3000067,,0,0.00,0,7,1
0,"A Gaulton, EC Uhalte, P Magarinos, G Papadatos, A Leach, T Oprea","Beyond journal articles-extracting bioactivity data from patents",2018,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",249,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:rmR93V40Y70C",256,,,,0,0.00,0,6,1
0,"T Oprea, O Ursu, C Bologa","AI-driven target selection in drug discovery-exploring the undiscovered country",2018,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",250,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:QvnCfHfiBIkC",256,,,,0,0.00,0,3,1
0,"T Oprea","Mining clinical trials information using text mining and cheminformatics technologies",2018,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",251,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:quBVm8e4N6QC",256,,,,0,0.00,0,1,1
0,"O Ursu, C Bologa, T Oprea","Chemical mixture evaluation using molecular-weight corrected fingerprints",2018,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",252,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:E4Dt5tAWU4sC",256,,,,0,0.00,0,3,1
0,"TI Oprea, CG Bologa, O Ursu, JY Choe, C Iancu","Human glut5 specific inhibitors and methods of treatment",2018,"US Patent App. 15","","","",253,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:boGf3zyra0UC",735,,840,840,0,0.00,0,5,1
0,"PK Nighot, T Borunda, L Laidler, M Wong, T Thompson, T Oprea, L Sklar, ...","264-Tocopherylquinone-Mediated Activation of Aryl Hydrocarbon Receptor Reduces Intestinal Epithelial Tight Junction Permeability and Severity of Experimental Colitis",2018,"Gastroenterology 154 (6), S","","","",254,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:tKAXkfz_euYC",65,,,,0,0.00,0,8,1
0,"J Gasteiger, Y Martin, A Nicholls, TI Oprea, T Stouch","Leaving us with fond memories, smiles, SMILES and, alas, tears: a tribute to David Weininger, 1952–2016",2018,"Journal of computer-aided molecular design","","","",255,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:8k3R5ScbChQC",32,2,313,319,0,0.00,0,5,1
0,"G Karlebach, DFT Veiga, AD Mays, AK Kesarwani, D Danis, G Kararigas, ...","The impact of sex on alternative splicing",2018,"BioRxiv","","","",256,"2019-05-16","Preprint","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:lOLSY4hLU6kC",490904,,,,0,0.00,0,7,1
0,"M Akamatsu, TI Oprea","Obituary: Toshio Fujita, QSAR pioneer",2017,"Journal of computer-aided molecular design","","","",257,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:dL6bBWYs_hoC",31,11,959,960,0,0.00,0,2,2
0,"T Oprea","Understudied proteins: Time to shift the paradigm",2017,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",258,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:vkG2KsohqNgC",254,,,,0,0.00,0,1,2
0,"A Wandinger-Ness, L Hudson, L Sklar, Z Surviladze, T Oprea","Modulators of gtpases and their use",2017,"US Patent App. 15","","","",259,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:4givWmz5LegC",445,,413,413,0,0.00,0,5,2
0,"S Mani, D Cannon, R Ohls, T Oprea, S Mathias, K Ballard, O Ursu, ...","Protein biomarker druggability profiling",2017,"Journal of biomedical informatics","","","",260,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:prdVHNxh-e8C",66,,241,247,0,0.00,0,8,2
0,"J Yang, T Oprea, D Wild","Integrative data science, semantics, knowledge graphs, and evidence paths in the service of molecular discovery",2016,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",261,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:PHsrdvypza0C",252,,,,0,0.00,0,3,3
0,"C Bologa, O Ursu, J Yang, T Oprea","Polypharmacology: Useful?",2016,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",262,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:mN77zE6YZBUC",252,,,,0,0.00,0,4,3
0,"T Oprea","Illuminating the druggable genome: Linking diseases, targets and drugs",2016,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",263,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Dqu_ECg3lNoC",252,,,,0,0.00,0,1,3
0,"YC Martin, R Abagyan, GG Ferenczy, VJ Gillet, TI Oprea, J Ulander, ...","Glossary of terms used in computational drug design, part II (IUPAC Recommendations)",2016,"","","","",264,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:3eDEwZmXtlkC",,,,,0,0.00,0,7,3
0,"CG Bologa, U Oleg, L Halip, R CURPĂN, TI Oprea","CHEMICAL AND BIOLOGICAL DESCRIPTOR INTEGRATION IMPROVES COMPUTATIONAL MODELING OF IN VIVO RAT TOXICITY",2015,"Revue roumaine du chimie 60 (2-3)","","","",265,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:4X0JR2_MtJMC",219,,,,0,0.00,0,5,4
0,"O Ursu, T Oprea, P Moseley, G Iwamoto, RV Guillamet","Clustering Chronic Obstructive Pulmonary Disease Subjects Using Administrative Data",2015,"Am J Respir Crit Care Med 191, A","","","",266,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:H4IpxOyCX80C",2847,,,,0,0.00,0,5,4
0,"RV Guillamet, O Ursu, T Oprea, P Moseley, G Iwamoto","B36 COME TOGETHER: COPD PHENOTYPES: Clustering Chronic Obstructive Pulmonary Disease Subjects Using Administrative Data",2015,"American Journal of Respiratory and Critical Care Medicine","","","",267,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:artPoR2Yc-kC",191,,1,1,0,0.00,0,5,4
0,"R Hromas, A Leitao, TI Oprea, LA Sklar, EA Williamson, J Wray, W Wang","Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer",2014,"US Patent 8","","","",268,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:Z5m8FVwuT1cC",889,,689,689,0,0.00,0,7,5
0,"T Oprea, S Schurer, A Mir, U Vempati, J Yang, O Ursu, C Bologa","Data curation and formal BioAssay Ontology (BAO)-based annotations of the DrugMatrix enable bioactivity-based target-relationship analysis and demonstrate incorporation of …",2013,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",269,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:DIP-VHrGjvwC",246,,,,0,0.00,0,7,6
0,"TI Oprea","Think local, act global: Some challenges in cheminformatics and drug research",2013,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",270,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:UX7E2m6xpKUC",246,,,,0,0.00,0,1,6
0,"JJ Yang, CG Bologa, DJ Wild, TI Oprea","Molecular scaffolds are special and useful guides to discovery",2013,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",271,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:ouq6-fJ2VSQC",246,,,,0,0.00,0,4,6
0,"TI Oprea, A Leitao, EE May, A Tropsha","Applied Systems Chemical Biology and the quest for novel agents against tuberculosis",2013,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",272,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:rR1SM4wcGAYC",246,,,,0,0.00,0,4,6
0,"R Guha, D Lahr, J Bittker, TDY Chung, M Southern, S Chatwin, JJ Yang, ...","BioAssay Research Database: A platform to support the collection, management, and analysis of chemical biology data",2013,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",273,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:rbgNTKsR3fAC",245,,,,0,0.00,0,8,6
0,"TI Oprea, C Bologa, S Mathias, J Abear, O Ursu, G Zahoransky-Kohalmi, ...","UNM Division of Biocomputing public web applications: Computational tools for cheminformatics and molecular discovery",2013,"","","","",274,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:tuHXwOkdijsC",,,,,0,0.00,0,7,6
0,"JE Bauman, GT Olson, M Spafford, M Nuara, S Sampath, SJ Lee, ...","A pilot study of raltegravir and cisplatin in head and neck squamous cell carcinoma (HNSCC).",2012,"Journal of Clinical Oncology 30 (15_suppl), TPS5602-TPS","","","",275,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:2KloaMYe4IUC",5602,,,,0,0.00,0,7,7
0,"R Hromas, A Leitao, TI Oprea, LA Sklar, EA Williamson, J Wray","Metnase and intnase inhibitors and their use in treating cancer",2012,"US Patent App. 13","","","",276,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:nrtMV_XWKgEC",255,,708,708,0,0.00,0,6,7
0,"JJ Yang, O Ursu, SL Mathias, CG Bologa, A Waller, AM Evangelisti, ...","Development of a screening informatics system at the UNM Center for Molecular Discovery, an NIH MLP specialty center",2012,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",277,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:lIeuKFitLToC",243,,,,0,0.00,0,7,7
0,"G Zahoranszky-Kohalmi, JJ Yang, CG Bologa, SL Mathias, O Ursu, ...","CARLSBAD (Confederated Annotated Research Libraries for Small molecule BioActivity Data): A database and its platform",2012,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",278,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:7AXAwFc_feUC",243,,,,0,0.00,0,6,7
0,"TI Oprea","Integrating targets, drugs and clinical outcomes into systems medicine",2012,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",279,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:lVu93_cgYy4C",243,,,,0,0.00,0,1,7
0,"O Taboureau, TI Oprea","System chemical biology studies of endocrine disruptors",2012,"242nd National Meeting of the American-Chemical-Society (ACS)","","","",280,"2019-05-16","Conference paper","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:wMgC3FpKEyYC",,,,,0,0.00,0,2,7
0,"A Wandinger-Ness, L Hong, SR Kenney, GK Phillips, D Simpson, ...","Specific Cell-Permeant Cdc42 Inhibitor Prevents GTPase Activation and Cellular Functions",2012,"MOLECULAR BIOLOGY OF THE CELL","","","",281,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:tH6gc1N1XXoC",23,,,,0,0.00,0,6,7
0,"C Hasselgren, H Chen, P Varkonyi, S Boyer, S Muresan, TI Oprea","In silico pharmacokinetic and toxicological profiling of natural products and drugs",2011,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",282,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:gyFZhc6YOh8C",242,,,,0,0.00,0,6,8
0,"O Ursu, JJ Yang, RF Curpan, L Ostopovici-Halip, CA Lipinski, LA Sklar, ...","Selective, privileged and promiscuous chemical patterns in high-throughput screening",2011,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",283,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:8U9l5EwV_MEC",242,,,,0,0.00,0,7,8
0,"A Wandinger-Ness, SR Kenney, J Agola, J Roxby, Z Surviladze, ...","Abstract LB-214: Rac1 and Cdc42 GTPases as novel targets in ovarian cancer",2011,"Cancer Research 71 (8 Supplement), LB-214-LB","","","",284,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:OP4eGU-M3BUC",214,,,,0,0.00,0,6,8
0,"O Taboureau, SK Nielsen, KML Audouze, N Weinhold, D Edsgärd, ...","ChemProt",2011,"Nucleic Acids Research","","","",285,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:blZQ8lPX3m0C",,,,,0,0.00,0,6,8
0,"O Ursu, CG Bologa, TI Oprea","Model-free drug-like filters",2010,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",286,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:W26WQ4UGDhEC",240,,,,0,0.00,0,3,9
0,"LA Sklar, PC Simons, A Waller, SM Biggs, SM Young, M Olah, C Bologa, ...","High‐Throughput Flow Cytometry",2010,"Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and …","","","",287,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:_kc_bZDykSQC",,,,,0,0.00,0,8,9
0,"GHG Trossini, A Leitão, TI Oprea, AD Andricopulo, EI Ferreira","Planejamento de fármacos baseado na estrutura: triagem virtual e avaliação bioquímica de novos inibidores da cruzaína de Trypanosoma cruzi",2010,"","","","",288,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:hQ3-0SoZo6AC",,,,,0,0.00,0,5,9
0,"GHG Trossini, A Leitão, T Oprea, AD Andricopulo, EI Ferreira","Structure-based drug design: virtual screening and biochemical evaluation of new Trypanosoma cruzi cruzain inhibitors",2010,"Brazilian Journal of Pharmaceutical Sciences 46, 93 res. FCF","","","",289,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:L9GP20v134kC",182,,,,0,0.00,0,5,9
0,"JW Bok, YM Chiang, E Szewczyk, Y Reyes-Dominguez, AD Davidson, ...","Corrigendum: Chromatin-level regulation of biosynthetic gene clusters",2009,"Nature Chemical Biology","","","",290,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:CB2v5VPnA5kC",5,9,696,696,0,0.00,0,6,10
0,"D MacKenzie, M Haynes, CA Hu, L Sklar, T Oprea, C Bologa, ...","Abstract# 5505: High-throughput screening of small molecule inducers of autophagy as potential therapies for prostate cancer",2009,"Cancer Research 69 (9 Supplement)","","","",291,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:F9fV5C73w3QC",5505,,,,0,0.00,0,7,10
0,"TI Oprea","Ro5. 1: Pfizer rules revisited",2009,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",292,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:ptF5elMcwUYC",237,,,,0,0.00,0,1,10
0,"TI Oprea","Cytochrome P450s in DrugMetabolism and Disease",2009,"","","","",293,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:e5wmG9Sq2KIC",,,,,0,0.00,0,1,10
0,"E May, M Misra, JL Faulon, A Leitao, TI Oprea","Systems chemical biology studies of enzymatic metabolic networks and inhibitors.",2008,"Sandia National Lab.(SNL-NM), Albuquerque, NM (United States)","","","",294,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:KbBQZpvPDL4C",,,,,0,0.00,0,5,11
0,"E May, A Leitao, JL Faulon, J Joo, M Misra, TI Oprea","CINF 10-Systems chemical biology modeling of virulence-related pathways of Mycobacterium tuberculosis",2008,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",295,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:L3c5sqbRKa8C",236,,,,0,0.00,0,6,11
0,"JJ Yang, CG Bologa, TI Oprea","COMP 141-Promiscuous patterns and perils in the NIH Molecular Libraries Initiative",2008,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",296,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:CUz-cjXBMXMC",236,,,,0,0.00,0,3,11
0,"JL Faulon, TI Oprea","COMP 91-Drug informatics: Relating drug to target",2008,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",297,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:lLDkS9sB7dAC",236,,,,0,0.00,0,2,11
0,"E Brailoiu, GC Brailoiu, S Le Dun, E Deliu, EA Ariazi, JB Arterburn, ...","COMP 28-Localization, distribution, and pharmacology of G protein-coupled estrogen receptor GPR30",2008,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",298,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:9tJtKg94vZsC",236,,,,0,0.00,0,7,11
0,"LA Sklar, Z Surviladze, GM Bokoch, CG Bologa, B Edwards, TI Oprea, ...","COMP 30-HTS and pharmacology of multiplexed small GTPase targets by flow cytometry",2008,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",299,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:LyOydA3uxaIC",236,,,,0,0.00,0,7,11
0,"TI Oprea","Is there a general model for bioactivity? An overview of the MLSMR-MLSCN bioassays",2008,"JOURNAL OF BIOMOLECULAR SCREENING","","","",300,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=200&pagesize=100&citation_for_view=2O0vLx8AAAAJ:vDijr-p_gm4C",13,7,713,714,0,0.00,0,1,11
0,"TI Oprea, SL Mathias, JJ Yang, CG Bologa","CINF 27-RoadRunner: A publicly available bioactivity database",2008,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",301,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:_b9rsmHxKOYC",235,,,,0,0.00,0,4,11
0,"TI Oprea","CINF 45-Safe exchange of chemical information: Not"" safe"" enough?",2008,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",302,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:sRzLl6AghiAC",235,,,,0,0.00,0,1,11
0,"SW Burchiel, TA Thompson, FT Lauer, TI Oprea","Corrigendum to “Activation of dioxin response element (DRE)-associated genes by benzo (a) pyrene 3, 6-quinone and benzo (a) pyrene 1, 6-quinone in MCF-10A human mammary …",2008,"Toxicology and Applied Pharmacology","","","",303,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:QobCCQ6YufAC",226,3,345,346,0,0.00,0,4,11
0,"L Zhang, H Zhu, TI Oprea, A Tropsha","COMP 345-QSAR modeling of blood-brain barrier permeability of diverse organic compounds",2007,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",304,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:sK9NQJKSZRcC",234,,,,0,0.00,0,4,12
0,"J Mestres, S Chemotargets, TI Oprea","CINF 6-GAUDI: An integrated tool for navigating through the small molecule-target protein space",2007,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",305,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:KjbfwUOO_FMC",234,,,,0,0.00,0,3,12
0,"AC Good, TI Oprea","COMP 266-Virtual screening enrichment studies: A help or hindrance in tool selection?",2007,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",306,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:WhXzBXCJJjMC",234,,,,0,0.00,0,2,12
0,"TI Oprea, TK Allu, DC Fara, O Ursu","COMP 177-Proof of the pudding: How predictive are QSAR models?",2007,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY","","","",307,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:N5ITjzxXrcwC",234,,,,0,0.00,0,4,12
0,"LA Sklar, J Arterburn, B Edwards, A Kiselyov, T Oprea, E Prossnitz","Novel targets for the NIH Roadman Molecular Libraries Initiative",2006,"NEUROPSYCHOPHARMACOLOGY 31, S65-S","","","",308,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:-_dYPAW6P2MC",66,,,,0,0.00,0,6,13
0,"SS Winter, DM Lovato, HM Khawaja, BS Edwards, ID Steele, SM Young, ...","Identification of Off-Patent Drugs That Reverse Daunorubicin Efflux Mediated by ABCB1 in T-ALL Cells.",2006,"Blood","","","",309,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:KUbvn5osdkgC",108,11,2603,2603,0,0.00,0,7,13
0,"V Paunescu, E Suciu, C Tatu, T Oprea","Isolation and purification of human insulin producing cells for the treatment of insulin dependent diabetes",2006,"US Patent App. 11","","","",310,"2019-05-16","Patent","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:M7yex6snE4oC",29,,541,541,0,0.00,0,4,13
0,"BS Edwards, J Arterburn, S Biggs, C Bologa, T Buranda, D Cimino, ...","Flow cytometry and the NIH Roadmap Molecular Libraries Screening Initiative",2006,"CYTOMETRY PART A","","","",311,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:BUYA1_V_uYcC",69,5,409,409,0,0.00,0,7,13
0,"I Olah, M Banda, Z Simon, M Mracec, TI Oprea","MariusOlah, MariaMracec, LilianaOstopovici, RamonaRad, AlinaBora, NicoletaHadaruga",2006,"Chemoinformatics in Drug Discovery","","","",312,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:tVzLobxzA7YC",,,,,0,0.00,0,5,13
0,"TI Oprea","11 Rapid ADME Filters for Lead Discovery* Tudor I. Oprea, Paolo Benedetti, Giuliano Berellini, Marius Olah, Kim Fejgin, and Scott Boyer",2006,"Molecular interaction fields: applications in drug discovery and ADME …","","","",313,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:r8lgQMkXaCEC",,,,,0,0.00,0,1,13
0,"CG Bologa, M Olah, TI Oprea","Confusing descriptors: Where chemical information gets dizzy.",2005,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 229, U762-U","","","",314,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:n94QCav8jycC",762,,,,0,0.00,0,3,14
0,"BS Edwards, SM Young, A Waller, C Bologa, T Oprea, ER Prossnitz, ...","Screening with HyperCyt (R) high-throughput flow cytometry to detect small-molecule formyl-peptide receptor ligands",2004,"CYTOMETRY PART A","","","",315,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:foquWX3nUaYC",59,1,31,32,0,0.00,0,7,15
0,"TI Oprea, CG Bologa","Priori vs. A posteriori: An exhaustive PLS search for biologically-relevant QSAR descriptors.",2004,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 227, U904-U","","","",316,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:kuAnG0LXj_AC",905,,,,0,0.00,0,2,15
0,"TI Oprea","Strategies for lead discovery oriented virtual screening.",2002,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 224, U340-U","","","",317,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:cKQgJgBA5EIC",341,,,,0,0.00,0,1,17
0,"M Mracec, TI Oprea, M Mracec","Correlation between experimental electron affinities for aromatic derivatives and the values calculated with semiempirical MO methods",2000,"REVUE ROUMAINE DE CHIMIE","","","",318,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:mVmsd5A6BfQC",45,10,949,954,0,0.00,0,3,19
0,"SJ Teague, AM Davis, PD Leeson, T Oprea","Die Optimierung von Leitverbindungen",1999,"ANGEWANDTE CHEMIE","","","",319,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:PV2Y7XyTJDgC",111,24,3962,3967,0,0.00,0,4,20
0,"TI Oprea","The hypothetical world of CoMFA and model validation",1996,"American Chemical Society, Washington, DC (United States)","","","",320,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:2lgwpy1Hu6IC",,,,,0,0.00,0,1,23
0,"ML Smythe, MJ Dooley, Y Strandberg, ML West, TE Ramsdale, RD Head, ...","The Analysis of Complexes from the Brookhaven Database for the Receptor-based Prediction of Binding Affinities of Novel Ligands",1996,"Chemical Design Automation News","","","",321,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:5icHVeHT4IsC",4,11,18,19,0,0.00,0,7,23
0,"RD HEAD, ML SMYTHE, SM GREEN, CMW HO, TI OPREA, ...","PREDICTION OF BINDING-AFFINITY OF LIGANDS TO RECEPTORS OF KNOWN STRUCTURE",1995,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 210, 2-COMP","","","",322,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:FQnhRx9bfrkC",,,,,0,0.00,0,6,24
0,"GR MARSHALL, RD HEAD, ML SMYTHE, SM GREEN, CMW HO, ...","PREDICTION OF AFFINITY-THE KEY TO DE-NOVO DRUG DESIGN",1995,"FASEB JOURNAL 9 (6), A1253-A","","","",323,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:WZBGuue-350C",1253,,,,0,0.00,0,6,24
0,"SM GREEN, RD HEAD, TI OPREA, CL WALLER, GR MARSHALL","NONSTATISTICAL PARADIGMS FOR 3D-QSAR",1994,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 208, 139-COMP","","","",324,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:FOZckGct7WUC",,,,,0,0.00,0,5,25
0,"CL WALLER, TI OPREA, A GIOLITTI, GR MARSHALL","Three‐Dimensional QSAR of Human Immunodeficiency Virus (I) Protease Inhibitors. Part 1. A CoMFA Study Employing Experimentally‐Determined Alignment Rules.",1994,"ChemInform 25 (26), no-no","","","",325,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:tFsQzMahPQAC",,,,,0,0.00,0,4,25
0,"GR MARSHALL, CMW HO, TI OPREA, CL WALLER","DE-NOVO DESIGN-LIGAND CONSTRUCTION AND PREDICTION OF AFFINITY",1994,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 207, 37-COMP","","","",326,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:8wCixH_E2vEC",,,,,0,0.00,0,4,25
0,"CL WALLER, TI OPREA, GR MARSHALL","3-D QSAR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE INHIBITORS",1993,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 206, 87-MEDI","","","",327,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:xEh6bupSuykC",,,,,0,0.00,0,3,26
0,"TI OPREA, CL WALLER, GR MARSHALL","VALIDATION OF A COMFA MODEL FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE INHIBITORS BASED ON MULTIPLE CONFORMER PREDICTIONS",1993,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 206, 88-MEDI","","","",328,"2019-05-16","Abstract","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:cwugQcE3IssC",,,,,0,0.00,0,3,26
0,"TI Oprea, L Kurunczi","MOLECULAR RECOGNITION DURING LIGAND-RECEPTOR INTERACTIONS. APPLICATIONS IN RECEPTOR MAPPING",1993,"Specific Interaction and Biological Recognition Processes","","","",329,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:BJbdYPG6LGMC",295,,,,0,0.00,0,2,26
0,"Z Surviladze, O Ursu, F Miscioscia, R Curpan, L Halip, C Bologa, T Oprea, ...","UNMCMD Probe Report Title: Three small molecule pan activator families of Ras-related GTPases",1769,"cell division","","","",330,"2019-05-16","Journal article","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:hC7cP41nSMkC",1050,,888706,888706,0,0.00,0,8,250
0,"JP Slack, A Brockhoff, C Batram, S Menzel, C Sonnabend, S Born, ...","Supplemental Information Modulation of Bitter Taste Perception by a Small Molecule hTAS2R Antagonist",,"","","","",331,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:cTdzRpWJKHEC",,,,,0,0.00,0,7,
0,"A Leitão, DC Fara, TI Oprea","Cheminformatics-Advanced: The role of pharmacokinetics/toxicity and the concept of drug-likeness",,"","","","",332,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:7H_MAutzIkAC",,,,,0,0.00,0,3,
0,"DC Fara, TI Oprea","Cheminformatics-Advanced: Data Analysis, Classification Methods, Quantitative Structure-Activity Relationships (QSAR)",,"","","","",333,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:WHdLCjDvYFkC",,,,,0,0.00,0,2,
0,"J Kringelum, SK Kjærulff, TI Oprea, S Brunak, OL Olivier","Supplementary information: ChemProt-3.0: A global chemical-biology diseases mapping",,"","","","",334,"2019-05-16","","","","https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2O0vLx8AAAAJ&cstart=300&pagesize=100&citation_for_view=2O0vLx8AAAAJ:nRpfm8aw39MC",,,,,0,0.00,0,5,
